ImmuCell Corporation announced a 11.5% increase in product sales for the second quarter of 2026 compared to the second quarter of 2025, according to preliminary, unaudited sales results. ImmuCell Corporation is a biotechnology company that develops and manufactures products for immune system regulation and regulation of the immune response.
